Latest Feature

Kimberly-Clark readies Halyard Health medical device spinout

Halyard Health, the publicly traded, $1.6 billion spinout of Kimberly-Clark's medical device business, is slated to go live in November, soon-to-be COO Chris Lowery tells MassDevice.com.

HART CEO David Green on the transformative potential for regenerative medicine

David Green tells MassDevice.com about the decision to split Harvard Bioscience and Harvard Apparatus Regenerative Technology, his choice to move over to the new entity and why regenerative technologies are poised to transform medicine.

Wound care by the numbers: Q&A with Alliqua CEO Dave Johnson

Medtech veteran Dave Johnson has been with Alliqua Biomedical for less than 2 years, during which time he's overseen a major hiring spree, 3 business development deals and the company's 1st acquisition. In an interview with MassDevice.com, Johnson talks about his step-by-step perspective and where he hopes Alliqua will be in 5 years.

Podcast: Medtech legends and leaders on the state of medical device innovation

MassDevice.com brought together 4 of the most influential leaders in medtech to discuss the future of the industry on July 15, 2014 at DeviceTalks Boston.

CardioMEMS took 11 years to pay off, but for Boston Millennia it was worth it

Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

TCT 2014 Roundup

September 15, 2014 by Brad Perriello

A roundup of studies released at the annual Transcatheter Cardiovascular Therapies conference in Washington this week.

TCT 2014 Roundup

Here's a look at some of the news coming out of Washington at the 26th annual Transcatheter Cardiovascular Therapies conference this week:

Digital health: Medtronic launches heart-monitoring patch

September 15, 2014 by Arezu Sarvestani

Medtech titan Medtronic launches U.S. sales of the SEEQ wearable heart monitor it picked up in this year's acquisition of Corventis.

Digital health: Medtronic launches wearable heart monitor

Medtronic (NYSE:MDT) is poised to make a big splash in remote patient monitoring with the commercial launch of its SEEQ skin-worn heart monitoring patch.

TCT 2014: Is renal denervation dead or alive?

September 15, 2014 by Brad Perriello

Is renal denervation for hypertension dead or alive? Experts agree that more studies are needed.

TCT 2014: Is renal denervation dead or alive?

The efficacy of renal denervation is in doubt and should be confirmed or ruled out in treating resistant hypertension, according to an expert panel in a debate over the once high-flying technology at the Transcatheter Cardiovascular Therapeutics conference in Washington.

Neurovascular: Covidien begins enrollment in 2 new trials

September 15, 2014 by Arezu Sarvestani

Covidien begins enrolling patients in clinical trials for its Pipeline embolization system as well as all its endovascular stroke devices.

Covidien begins enrollment for 2 new trials

Covidien (NYSE:COV) announced today that it enrolled the 1st patients in a pair of clinical trials evaluating the company's neurovascular technologies.

MassDevice.com +3 | The top 3 medtech stories for September 15, 2014

September 15, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

TCT 2014: TAVI takes center stage

September 15, 2014 by Brad Perriello

Transcatheter aortic valve implants take center stage at the annual Transcatheter Cardiovascular Therapeutics conference with the latest data dumps from rivals Medtronic and Edwards Lifesciences.

TCT 2014: TAVI takes center stage

Corindus raises $26.6M for vascular robot

September 15, 2014 by Arezu Sarvestani

Corindus Vascular Robotics plans to boost its commercial efforts with the $26.6 million it closed in a private placement round.

Corindus raises $26.6M for vascular robot

Massachusetts-based Corindus Vascular Robotics has big plans for its newly secured $26.6 million, raised in a private placement funding round.

Corindus sold nearly 10.7 million shares at $2.50 apiece through a Securities Purchase Agreement, with Cowen & Co. and Stifel, Nicolaus & Co. acting as placement agents.

Danaher becomes dental giant with $2.1B Nobel Biocare buy

September 15, 2014 by Arezu Sarvestani

The $2.14 billion acquisition of Nobel Biocare will turn Danaher into the largest dental implants provider in the world.

Danaher becomes dental giant with $2.1B Nobel Biocare buy
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp